Global Vaccine (Include COVID-19) market size is predicted to grow from US$ 60590 million in 2025 to US$ 75720 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031. Get Access Now!

Global Vaccine Include COVID-19 Market Growth Status and Outlook 2025-2031

The global Vaccine (Include COVID-19) market size is predicted to grow from US$ 60590 million in 2025 to US$ 75720 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031. A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the bodys immune system to recognize the agent as foreign, destroy it, and remember it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Vaccine (Include COVID-19) Industry Forecast looks at past sales and reviews total world Vaccine (Include COVID-19) sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine (Include COVID-19) sales for 2025 through 2031. With Vaccine (Include COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine (Include COVID-19) industry. This Insight Report provides a comprehensive analysis of the global Vaccine (Include COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine (Include COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Vaccine (Include COVID-19) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine (Include COVID-19) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine (Include COVID-19). This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine (Include COVID-19) market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Inactivated Vaccine &nbsp;&nbsp;&nbsp; Attenuated Vaccine &nbsp;&nbsp;&nbsp; mRNA &nbsp;&nbsp;&nbsp; Other Segmentation by Application: &nbsp;&nbsp;&nbsp; Public &nbsp;&nbsp;&nbsp; Private This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; CSL &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Viatris &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Hualan Bio &nbsp;&nbsp;&nbsp; Changchun Institute of Biological &nbsp;&nbsp;&nbsp; Sinovac &nbsp;&nbsp;&nbsp; KM Biologics &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Sinovac &nbsp;&nbsp;&nbsp; Zhejiang Pukang &nbsp;&nbsp;&nbsp; Walvax Biotechnology &nbsp;&nbsp;&nbsp; Bharat Biotech &nbsp;&nbsp;&nbsp; Serum Institute &nbsp;&nbsp;&nbsp; Panacea Biotec Ltd &nbsp;&nbsp;&nbsp; Bio-Med &nbsp;&nbsp;&nbsp; Halfkin Bio-Pharmaceuticals &nbsp;&nbsp;&nbsp; LG Life Sciences

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Vaccine (Include COVID-19) Market Size (2020-2031) &nbsp;2.1.2 Vaccine (Include COVID-19) Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Vaccine (Include COVID-19) by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Vaccine (Include COVID-19) Segment by Type &nbsp;2.2.1 Inactivated Vaccine &nbsp;2.2.2 Attenuated Vaccine &nbsp;2.2.3 mRNA &nbsp;2.2.4 Other &nbsp;2.3 Vaccine (Include COVID-19) Market Size by Type &nbsp;2.3.1 Vaccine (Include COVID-19) Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Vaccine (Include COVID-19) Market Size Market Share by Type (2020-2025) &nbsp;2.4 Vaccine (Include COVID-19) Segment by Application &nbsp;2.4.1 Public &nbsp;2.4.2 Private &nbsp;2.5 Vaccine (Include COVID-19) Market Size by Application &nbsp;2.5.1 Vaccine (Include COVID-19) Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Vaccine (Include COVID-19) Market Size Market Share by Application (2020-2025) 3 Vaccine (Include COVID-19) Market Size by Player &nbsp;3.1 Vaccine (Include COVID-19) Market Size Market Share by Player &nbsp;3.1.1 Global Vaccine (Include COVID-19) Revenue by Player (2020-2025) &nbsp;3.1.2 Global Vaccine (Include COVID-19) Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Vaccine (Include COVID-19) Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Vaccine (Include COVID-19) by Region &nbsp;4.1 Vaccine (Include COVID-19) Market Size by Region (2020-2025) &nbsp;4.2 Global Vaccine (Include COVID-19) Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Vaccine (Include COVID-19) Market Size Growth (2020-2025) &nbsp;4.4 APAC Vaccine (Include COVID-19) Market Size Growth (2020-2025) &nbsp;4.5 Europe Vaccine (Include COVID-19) Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Vaccine (Include COVID-19) Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Vaccine (Include COVID-19) Market Size by Country (2020-2025) &nbsp;5.2 Americas Vaccine (Include COVID-19) Market Size by Type (2020-2025) &nbsp;5.3 Americas Vaccine (Include COVID-19) Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Vaccine (Include COVID-19) Market Size by Region (2020-2025) &nbsp;6.2 APAC Vaccine (Include COVID-19) Market Size by Type (2020-2025) &nbsp;6.3 APAC Vaccine (Include COVID-19) Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Vaccine (Include COVID-19) Market Size by Country (2020-2025) &nbsp;7.2 Europe Vaccine (Include COVID-19) Market Size by Type (2020-2025) &nbsp;7.3 Europe Vaccine (Include COVID-19) Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Vaccine (Include COVID-19) by Region (2020-2025) &nbsp;8.2 Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Vaccine (Include COVID-19) Market Forecast &nbsp;10.1 Global Vaccine (Include COVID-19) Forecast by Region (2026-2031) &nbsp;10.1.1 Global Vaccine (Include COVID-19) Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Vaccine (Include COVID-19) Forecast &nbsp;10.1.3 APAC Vaccine (Include COVID-19) Forecast &nbsp;10.1.4 Europe Vaccine (Include COVID-19) Forecast &nbsp;10.1.5 Middle East & Africa Vaccine (Include COVID-19) Forecast &nbsp;10.2 Americas Vaccine (Include COVID-19) Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Vaccine (Include COVID-19) Forecast &nbsp;10.2.2 Canada Market Vaccine (Include COVID-19) Forecast &nbsp;10.2.3 Mexico Market Vaccine (Include COVID-19) Forecast &nbsp;10.2.4 Brazil Market Vaccine (Include COVID-19) Forecast &nbsp;10.3 APAC Vaccine (Include COVID-19) Forecast by Region (2026-2031) &nbsp;10.3.1 China Vaccine (Include COVID-19) Market Forecast &nbsp;10.3.2 Japan Market Vaccine (Include COVID-19) Forecast &nbsp;10.3.3 Korea Market Vaccine (Include COVID-19) Forecast &nbsp;10.3.4 Southeast Asia Market Vaccine (Include COVID-19) Forecast &nbsp;10.3.5 India Market Vaccine (Include COVID-19) Forecast &nbsp;10.3.6 Australia Market Vaccine (Include COVID-19) Forecast &nbsp;10.4 Europe Vaccine (Include COVID-19) Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Vaccine (Include COVID-19) Forecast &nbsp;10.4.2 France Market Vaccine (Include COVID-19) Forecast &nbsp;10.4.3 UK Market Vaccine (Include COVID-19) Forecast &nbsp;10.4.4 Italy Market Vaccine (Include COVID-19) Forecast &nbsp;10.4.5 Russia Market Vaccine (Include COVID-19) Forecast &nbsp;10.5 Middle East & Africa Vaccine (Include COVID-19) Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Vaccine (Include COVID-19) Forecast &nbsp;10.5.2 South Africa Market Vaccine (Include COVID-19) Forecast &nbsp;10.5.3 Israel Market Vaccine (Include COVID-19) Forecast &nbsp;10.5.4 Turkey Market Vaccine (Include COVID-19) Forecast &nbsp;10.6 Global Vaccine (Include COVID-19) Forecast by Type (2026-2031) &nbsp;10.7 Global Vaccine (Include COVID-19) Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Vaccine (Include COVID-19) Forecast 11 Key Players Analysis &nbsp;11.1 Sanofi &nbsp;11.1.1 Sanofi Company Information &nbsp;11.1.2 Sanofi Vaccine (Include COVID-19) Product Offered &nbsp;11.1.3 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Sanofi Main Business Overview &nbsp;11.1.5 Sanofi Latest Developments &nbsp;11.2 CSL &nbsp;11.2.1 CSL Company Information &nbsp;11.2.2 CSL Vaccine (Include COVID-19) Product Offered &nbsp;11.2.3 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 CSL Main Business Overview &nbsp;11.2.5 CSL Latest Developments &nbsp;11.3 GSK &nbsp;11.3.1 GSK Company Information &nbsp;11.3.2 GSK Vaccine (Include COVID-19) Product Offered &nbsp;11.3.3 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 GSK Main Business Overview &nbsp;11.3.5 GSK Latest Developments &nbsp;11.4 Viatris &nbsp;11.4.1 Viatris Company Information &nbsp;11.4.2 Viatris Vaccine (Include COVID-19) Product Offered &nbsp;11.4.3 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Viatris Main Business Overview &nbsp;11.4.5 Viatris Latest Developments &nbsp;11.5 AstraZeneca &nbsp;11.5.1 AstraZeneca Company Information &nbsp;11.5.2 AstraZeneca Vaccine (Include COVID-19) Product Offered &nbsp;11.5.3 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 AstraZeneca Main Business Overview &nbsp;11.5.5 AstraZeneca Latest Developments &nbsp;11.6 Hualan Bio &nbsp;11.6.1 Hualan Bio Company Information &nbsp;11.6.2 Hualan Bio Vaccine (Include COVID-19) Product Offered &nbsp;11.6.3 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Hualan Bio Main Business Overview &nbsp;11.6.5 Hualan Bio Latest Developments &nbsp;11.7 Changchun Institute of Biological &nbsp;11.7.1 Changchun Institute of Biological Company Information &nbsp;11.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered &nbsp;11.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Changchun Institute of Biological Main Business Overview &nbsp;11.7.5 Changchun Institute of Biological Latest Developments &nbsp;11.8 Sinovac &nbsp;11.8.1 Sinovac Company Information &nbsp;11.8.2 Sinovac Vaccine (Include COVID-19) Product Offered &nbsp;11.8.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Sinovac Main Business Overview &nbsp;11.8.5 Sinovac Latest Developments &nbsp;11.9 KM Biologics &nbsp;11.9.1 KM Biologics Company Information &nbsp;11.9.2 KM Biologics Vaccine (Include COVID-19) Product Offered &nbsp;11.9.3 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 KM Biologics Main Business Overview &nbsp;11.9.5 KM Biologics Latest Developments &nbsp;11.10 Pfizer &nbsp;11.10.1 Pfizer Company Information &nbsp;11.10.2 Pfizer Vaccine (Include COVID-19) Product Offered &nbsp;11.10.3 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Pfizer Main Business Overview &nbsp;11.10.5 Pfizer Latest Developments &nbsp;11.11 Merck &nbsp;11.11.1 Merck Company Information &nbsp;11.11.2 Merck Vaccine (Include COVID-19) Product Offered &nbsp;11.11.3 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Merck Main Business Overview &nbsp;11.11.5 Merck Latest Developments &nbsp;11.12 Sinovac &nbsp;11.12.1 Sinovac Company Information &nbsp;11.12.2 Sinovac Vaccine (Include COVID-19) Product Offered &nbsp;11.12.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Sinovac Main Business Overview &nbsp;11.12.5 Sinovac Latest Developments &nbsp;11.13 Zhejiang Pukang &nbsp;11.13.1 Zhejiang Pukang Company Information &nbsp;11.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Offered &nbsp;11.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Zhejiang Pukang Main Business Overview &nbsp;11.13.5 Zhejiang Pukang Latest Developments &nbsp;11.14 Walvax Biotechnology &nbsp;11.14.1 Walvax Biotechnology Company Information &nbsp;11.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Offered &nbsp;11.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Walvax Biotechnology Main Business Overview &nbsp;11.14.5 Walvax Biotechnology Latest Developments &nbsp;11.15 Bharat Biotech &nbsp;11.15.1 Bharat Biotech Company Information &nbsp;11.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Offered &nbsp;11.15.3 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 Bharat Biotech Main Business Overview &nbsp;11.15.5 Bharat Biotech Latest Developments &nbsp;11.16 Serum Institute &nbsp;11.16.1 Serum Institute Company Information &nbsp;11.16.2 Serum Institute Vaccine (Include COVID-19) Product Offered &nbsp;11.16.3 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Serum Institute Main Business Overview &nbsp;11.16.5 Serum Institute Latest Developments &nbsp;11.17 Panacea Biotec Ltd &nbsp;11.17.1 Panacea Biotec Ltd Company Information &nbsp;11.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered &nbsp;11.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 Panacea Biotec Ltd Main Business Overview &nbsp;11.17.5 Panacea Biotec Ltd Latest Developments &nbsp;11.18 Bio-Med &nbsp;11.18.1 Bio-Med Company Information &nbsp;11.18.2 Bio-Med Vaccine (Include COVID-19) Product Offered &nbsp;11.18.3 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.18.4 Bio-Med Main Business Overview &nbsp;11.18.5 Bio-Med Latest Developments &nbsp;11.19 Halfkin Bio-Pharmaceuticals &nbsp;11.19.1 Halfkin Bio-Pharmaceuticals Company Information &nbsp;11.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered &nbsp;11.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.19.4 Halfkin Bio-Pharmaceuticals Main Business Overview &nbsp;11.19.5 Halfkin Bio-Pharmaceuticals Latest Developments &nbsp;11.20 LG Life Sciences &nbsp;11.20.1 LG Life Sciences Company Information &nbsp;11.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Offered &nbsp;11.20.3 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.20.4 LG Life Sciences Main Business Overview &nbsp;11.20.5 LG Life Sciences Latest Developments 12 Research Findings and Conclusion

Report	Global Vaccine (Include COVID-19) Market Growth (Status and Outlook) 2025-2031
Selected License	Single ID:LPI35789

Buyer Information

Order Summary